XML 27 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended 36 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2022
Cash flows from operating activities:        
Net earnings/(loss) $ (932) $ 612 $ (3,693)  
Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:        
Depreciation and amortization 692 783 913  
Impairments and loss on sale of other investments 24 0 0  
(Gain)/Loss on sale of equity interest in naviHealth 2 (2) 579  
Impairments and (gain)/loss on disposal of assets, net 2,050 79 7  
Loss on early extinguishment of debt 10 14 16  
Share-based compensation 81 89 90  
Provision for/(benefit from) deferred income taxes 7 496 (961)  
Provision for bad debts 68 65 106  
Change in operating assets and liabilities, net of effects from acquisitions and divestitures:        
(Increase)/decrease in trade receivables (1,526) (904) 82  
Increase in inventories (1,071) (1,584) (409)  
Increase/(decrease) in accounts payable 3,428 2,325 (162)  
Other accrued liabilities and operating items, net 293 452 6,550  
Net cash provided by operating activities 3,122 2,429 1,960  
Cash flows from investing activities:        
Proceeds from divestitures, net of cash sold 923 0 0  
Acquisition of subsidiaries, net of cash acquired (22) (3) 0  
Additions to property and equipment (387) (400) (375)  
Proceeds from disposal of property and equipment 31 0 2  
Purchase of other investments (78) (22) (20)  
Proceeds from sale of investments 29 47 886  
Proceeds from net investment hedge terminations 71 0 0  
Net cash provided by/(used in) investing activities 567 (378) 493  
Cash flows from financing activities:        
Net change in short-term borrowings 0 0 (2)  
Proceeds from interest rate swap terminations 0 18 112  
Reduction of long-term obligations (885) (570) (1,399)  
Net tax proceeds/(withholding) from share-based compensation (19) 8 8  
Dividends on common shares (559) (573) (569)  
Purchase of treasury shares (1,000) (200) (350)  
Net cash used in financing activities (2,463) (1,317) (2,200)  
Effect of exchange rates changes on cash and equivalents (25) 11 (13)  
Cash reclassified from/(to) assets held for sale 109 (109) 0  
Net increase in cash and equivalents 1,310 636 240  
Cash and equivalents at beginning of period 3,407 2,771 2,531 $ 2,531
Cash and equivalents at end of period 4,717 3,407 2,771 $ 4,717
Supplemental Information:        
Cash payments for interest 153 182 226  
Net cash payments/(refunds) for income taxes $ (766) $ 273 $ 368